Amplifon | AMP - Sales Revenues

Stock Price
13.31
Daily Change
0.34 2.64%
Monthly
-0.88%
Yearly
-45.66%
Q1 Forecast
12.83

Amplifon reported EUR563.3M in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Amplifon EUR 563.3M 29.55M Sep/2025
Avanos Medical USD 180.9M 3.1M Dec/2025
Brookdale Senior Living USD 813.16M 34.92M Sep/2025
Cencora USD 85.9B 5.2B Sep/2025
Diasorin EUR 280M 26M Sep/2025
Encompass Health USD 1.54B 60M Dec/2025
Enovis USD 548.9M 15.64M Sep/2025
GE HealthCare Technologies USD 5.14B 137M Sep/2025
OPKO Health USD 151.67M 5.14M Sep/2025
Pediatrix Medical Group USD -101.34M 126.58M Dec/2024
Veradigm USD 151.9M 1M Sep/2022
Zimmer Biomet Holdings USD 2.24B 240M Dec/2025